Class I - Dangerous
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Seatex
Class I - Dangerous
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class I - Dangerous
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications